U.S. markets closed
  • S&P Futures

    4,349.50
    +6.25 (+0.14%)
     
  • Dow Futures

    33,849.00
    +51.00 (+0.15%)
     
  • Nasdaq Futures

    15,033.75
    +9.75 (+0.06%)
     
  • Russell 2000 Futures

    2,185.50
    +4.60 (+0.21%)
     
  • Crude Oil

    70.51
    -0.05 (-0.07%)
     
  • Gold

    1,778.20
    0.00 (0.00%)
     
  • Silver

    22.77
    +0.16 (+0.73%)
     
  • EUR/USD

    1.1722
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    1.3240
    +0.0150 (+1.15%)
     
  • Vix

    24.36
    -1.35 (-5.25%)
     
  • GBP/USD

    1.3650
    -0.0014 (-0.11%)
     
  • USD/JPY

    109.4590
    +0.2390 (+0.22%)
     
  • BTC-USD

    42,203.91
    -448.77 (-1.05%)
     
  • CMC Crypto 200

    1,044.67
    -19.18 (-1.80%)
     
  • FTSE 100

    6,980.98
    +77.07 (+1.12%)
     
  • Nikkei 225

    29,688.65
    -151.06 (-0.51%)
     

BioLife Solutions Announces Changes to Board of Directors

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Chairman of the Board Raymond W. Cohen Retires After 15 Years of Service

CEO Mike Rice Elected Chairman

BOTHELL, Wash., July 14, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced changes to its board of directors.

BioLife Solutions New Logo 2021 (PRNewsfoto/BioLife Solutions, Inc.)
BioLife Solutions New Logo 2021 (PRNewsfoto/BioLife Solutions, Inc.)

Raymond W. Cohen, the Chief Executive Officer of Axonics, Inc. (Nasdaq: AXNX), joined the BioLife board in 2006 and has served as chairman since 2013 in addition to serving on, or chairing, various committees during his tenure. His resignation from the board was effective as of July 12th, 2021.

Mike Rice commented, "On behalf of all stakeholders of BioLife, we thank Ray for his many years of service for which we are sincerely grateful. His experience, mentorship and board leadership have been instrumental in helping craft our strategy and drive our growth at BioLife."

Current Chief Executive Officer and director, Mike Rice, has been appointed by the board of directors as the new chairman.

Mr. Cohen remarked, "It's been my sincere pleasure over the last 15 years to help Mike and the management team grow BioLife into a leading provider of bioproduction tools for the cell and gene therapy market. BioLife has a great future and I look forward to seeing continued product adoption and financial performance led by Mr. Rice and the new President, Mr. Dusty Tenney."

About BioLife Solutions

BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Our portfolio includes our proprietary CryoStor® freeze media and HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, Custom Biogenic Systems® high-capacity cryogenic freezers, Stirling Ultracold® ULT freezers, and SciSafe® biologic materials storage. For more information, please visit www.biolifesolutions.com, www.scisafe.com, and www.stirlingultracold.com, and follow BioLife on Twitter.

Media & Investor Relations

Roderick de Greef
Chief Financial Officer
(425) 686-6002

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-announces-changes-to-board-of-directors-301333257.html

SOURCE BioLife Solutions, Inc.